Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	417.92	422.64	352.98	147.46	121.79	62.2
Trading Asset Securities	-	-	-	200.31	341.06	-
Cash & Short-Term Investments	417.92	422.64	352.98	347.78	462.85	62.2
Cash Growth	18.40%	19.73%	1.50%	-24.86%	644.14%	14.12%
Accounts Receivable	371.77	374.28	318.43	326.39	222.79	119.56
Other Receivables	16.55	16.83	10.47	13.56	12.03	10
Receivables	388.32	391.11	328.89	339.95	234.82	129.55
Inventory	478.75	406.92	226.46	135.51	106.21	47.11
Other Current Assets	159.14	131.08	141.7	39.81	48.62	22.72
Total Current Assets	1,444	1,352	1,050	863.06	852.5	261.58
Property, Plant & Equipment	3,279	3,213	2,620	951.83	528.43	411.61
Long-Term Investments	123.68	123.45	112.4	40	7	2
Other Intangible Assets	114.48	137.73	86.28	73.17	43.98	41.53
Long-Term Deferred Tax Assets	90.09	86.54	49.39	40.48	14.39	18.93
Long-Term Deferred Charges	9.12	5.79	-	-	-	-
Other Long-Term Assets	92.82	71.17	51.9	58.54	27.8	7.24
Total Assets	5,153	4,989	3,970	2,027	1,474	742.89
Accounts Payable	588.15	564.03	589.01	221.64	99.87	86.84
Accrued Expenses	33.33	44	36.87	35.06	17.95	9.61
Short-Term Debt	491.25	681.98	915.12	79.23	18.5	55.07
Current Portion of Long-Term Debt	182.26	225.75	26.6	-	-	-
Current Income Taxes Payable	17.83	4.92	25.5	5.32	6.67	7.99
Current Unearned Revenue	18.16	17.4	12.77	19.61	17.57	1.68
Other Current Liabilities	72.52	65.45	70.61	27.9	22.34	0.45
Total Current Liabilities	1,404	1,604	1,676	388.75	182.89	161.64
Long-Term Debt	956.57	637.81	304.93	-	-	-
Long-Term Unearned Revenue	84.56	87.62	91.53	102.63	86.23	72.61
Long-Term Deferred Tax Liabilities	99.84	102.07	71.64	54.05	21.85	18.86
Total Liabilities	2,544	2,431	2,145	545.44	290.98	253.11
Common Stock	249.72	249.72	157.54	108.4	108.4	81
Additional Paid-In Capital	1,210	1,209	603.46	624.47	588.04	41.93
Retained Earnings	1,210	1,158	1,110	758.99	498.69	366.85
Treasury Stock	-53.61	-53.61	-45.24	-12	-12	-
Comprehensive Income & Other	0.94	0.96	0.72	0.64	-	-
Total Common Equity	2,617	2,565	1,827	1,480	1,183	489.78
Minority Interest	-8.23	-6.27	-1.31	1.15	-	-
Shareholders' Equity	2,608	2,558	1,826	1,482	1,183	489.78
Total Liabilities & Equity	5,153	4,989	3,970	2,027	1,474	742.89
Total Debt	1,630	1,546	1,247	79.23	18.5	55.07
Net Cash (Debt)	-1,212	-1,123	-893.67	268.55	444.35	7.13
Net Cash Growth	-	-	-	-39.56%	6128.38%	-
Net Cash Per Share	-5.20	-4.86	-3.90	1.18	2.14	0.04
Filing Date Shares Outstanding	255.48	235.72	227.71	227.91	227.91	227.07
Total Common Shares Outstanding	255.48	235.72	227.71	227.91	227.91	170.3
Working Capital	40.62	-251.78	-626.43	474.3	669.61	99.94
Book Value Per Share	10.24	10.88	8.02	6.50	5.19	2.88
Tangible Book Value	2,502	2,427	1,741	1,407	1,139	448.25
Tangible Book Value Per Share	9.79	10.30	7.64	6.17	5.00	2.63
Buildings	-	755.99	462.42	290.67	200.66	174.22
Machinery	-	1,307	952.21	703.78	439.11	349.07
Construction In Progress	-	1,606	1,529	188.91	65.33	21.17

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.